Thousands of melanoma patients in Europe have no access to new drugs

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen. Metastatic melanoma is an aggressive and deadly skin cancer. With...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2djsJv6
via IFTTT